Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Web Exclusives

Predicting Which Patients with Chronic Lymphocytic Leukemia Might Need Early Treatment
Web Exclusives — April 15, 2021
A new laboratory-based scoring system may allow physicians to better predict which patients with early-stage CLL are most likely to require early treatment. Read More ›

Evaluating the Risk of Severe COVID-19 in Patients with Chronic Lymphocytic Leukemia
Web Exclusives — April 15, 2021
Patients with CLL may be at increased risk for developing severe COVID-19. Experts have provided insights on how to protect them while still delivering optimal care. Read More ›

Zanubrutinib Now Recommended for Certain Patients with Chronic Lymphocytic Leukemia
Web Exclusives — April 15, 2021
Updated National Comprehensive Cancer Network (NCCN) guidelines now recommend zanubrutinib as alternative first- and second-line therapy for some patients. Read More ›

A Look at Cannabis Extracts for Patients with Chronic Lymphocytic Leukemia
Web Exclusives — April 15, 2021
Cannabis compounds such as cannabidiol have shown cancer-fighting activity in the lab. What should patients know? Read More ›

Disparities in the Treatment and Care of Minority Patients with Cancer
Web Exclusives — April 5, 2021
April is National Minority Health Month and National Minority Cancer Awareness Month, a time to reflect and shine a light on the disparities that minority populations face in cancer care. Read More ›

Moving Toward a Better Understanding of the Chronic Lymphocytic Leukemia Patient Experience
Web Exclusives — March 23, 2021
A new model of the symptoms and impacts faced by patients may lead to better clinical tools for understanding the patient experience. Read More ›

Watchful Waiting with Chronic Lymphocytic Leukemia
Web Exclusives — March 23, 2021
Patients who are in a period of active observation should feel comfortable sharing anything that seems abnormal with their healthcare provider. Read More ›

The Impact of Comorbid Health Conditions on Survival in Chronic Lymphocytic Leukemia
Web Exclusives — March 23, 2021
A greater number of comorbidities alone may not be sufficient to predict patient survival; age and stage at diagnosis must be considered as well. Read More ›

Acalabrutinib Shown to Be as Effective as Ibrutinib in Chronic Lymphocytic Leukemia with Less Atrial Fibrillation
Web Exclusives — March 23, 2021
The first phase 3 trial comparing these drugs shows that acalabrutinib has similar efficacy as ibrutinib with a lower risk of a worrisome side effect. Read More ›

CONQUER Celebrates Social Workers Everywhere
Web Exclusives — March 16, 2021
Social workers serve as “dot connectors” to help patients with cancer overcome barriers. Today, on World Social Work Day, CONQUER magazine celebrates social workers everywhere. Read More ›

Page 9 of 26